# Progress Note 01 — Initial plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Gilda Radner (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML026-SYN-TD
- Date: 1986-04-06
- Fictional facility: St. Posthumous Health Center
- Fictional author: Delia Marchand, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Subjective

The patient participates in this fictional visit for four weeks of bloating, early fullness and pelvic pain in a woman of 39: symptom index, pelvic examination, CA-125, and same-week imaging. **S**

## Objective

Hemoglobin: 12.4 g/dL; White cell count: 7.8 10*3/uL; Platelets: 412 10*3/uL (high); Sodium: 136 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.72 mg/dL; eGFR: 109 mL/min/1.73 m²; Glucose: 88 mg/dL; Calcium: 9.4 mg/dL; ALT: 18 U/L; AST: 22 U/L; Alkaline phosphatase: 84 U/L; Total bilirubin: 0.5 mg/dL; Albumin: 3.6 g/dL; CA-125: 1240 U/mL (high); CEA: 1.6 ng/mL; PHQ-2: 1; Pain, worst in the past week (0 to 10): 5. All results are synthetic.

BP 118/74 mmHg; pulse 92 bpm; respirations 16/min; temperature 36.9 °C; oxygen saturation 98% on room air; weight 58.5 kg; BMI 22.9 kg/m². All vital signs are synthetic.

## Assessment

Active problems: Persistent bloating with tightness of her clothes, feeling full after a few bites, a dull lower abdominal and pelvic ache, and passing urine more often, on most days for about four weeks, in a woman of 39: the ovarian cancer symptom index is positive. Examination: a distended abdomen with shifting dullness and a firm, fixed, irregular mass in the right adnexa. Suspected ovarian cancer; transvaginal ultrasound, CT, CA-125 and gynecologic oncology review booked within the week; Family history of ovarian cancer in three relatives (her grandmother, an aunt, and a cousin) in a woman of Ashkenazi Jewish ancestry; no genetic testing in the family is known. Strengths and supports remain part of the care plan. **S**

## Medication changes

- No medication changes. **S**

## Plan

- Urgent gynecologic oncology consultation for a suspected ovarian cancer, before any surgery, to confirm the diagnosis and plan primary treatment. Guideline: NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 4.2026 (2026); Committee Opinion No. 716: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk (2017) **S**
- At the first visit: the ovarian cancer symptom index, an abdominal and pelvic examination, CA-125 with CEA, blood count and chemistry, and a urine pregnancy test; transvaginal ultrasound and CT of the chest, abdomen and pelvis within the week, and image-guided biopsy if the scan shows disease outside the pelvis. Guideline: NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 4.2026 (2026); Goff BA, et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer 2007;109(2):221-227 (2007); Committee Opinion No. 716: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk (2017) **S**
